CFAR publications - alcohol and other drugs

The Centre includes researchers from across the Faculty of Medical and Health Sciences who have a long history examining issues associated with alcohol and other drug use in New Zealand.

 

Recent alcohol research addresses topics such as:

  • screening and brief interventions
  • patterns of alcohol consumption, alcohol and injury
  • youth use of alcohol
  • treatment options
  • cultural perspectives and practices
  • alcohol and pregnancy
  • the pharmacokinetics of alcohol.

Research into illicit drug use in New Zealand includes:

  • cannabis use
  • opioid substitution programmes
  • prescription drug misuse
  • impacts of methamphetamine use
  • cognitive effects of drug use
  • the effect of addictions on families
  • the psycho-pharmacology of various drug actions.

A number of recent projects have also focused on emergent synthetic and combination drugs (e.g. party pills, Kronic, Fantasy) and this research has been used in government policy decisions.

Selected publications since 2005


2014-2015

FALKNER, C., CHRISTIE, G., ZHOU, L., KING, J. (2015). The effect of alcohol price on dependent drinkers’ alcohol consumption. New Zealand Medical Journal. In press.

CHRISTIE, G. and V. MacFARLANE (2015). Synthetic cannabinoid presentations decline following ban. Drug Alcohol Rev. In press.

NEWCOMBE, D. A. L. WALKER, N., SHERIDAN, J., GALEA, S. (2015). The effect of varenicline administration on cannabis and tobacco use in cannabis and nicotine dependent individuals - a case-series. Journal of Addiction Research & Therapy, 6(2). doi:10.4172/2155-6105.1000222

MacFARLANE, V. and G. CHRISTIE (2015). Synthetic cannabinoid withdrawal: A new demand on detoxification services. Drug Alcohol Rev 34: 147-153

JACKSON N, DENNY S, AMERATUNGA S. (2014) Social and demographic neighbourhood effects on adolescent alcohol use: a systematic review of multi-level studies. Social Science and Medicine, 2014 115:10-20 DOI: 10.1016/j.socscimed.2014.06.004

JACKSON N, DENNY S, SHERIDAN J, FLEMING T, CLARK T, BEEVALE T, AMERATUNGA S. (2014). Predictors of drinking patterns in adolescence: A Latent class analysis. Drug and Alcohol Dependence, 2014 135:133-139 http://dx.doi.org/10.1016/j.drugalcdep.2013.11.021

KOOL B, SMITH E, RAERINA K, AMERATUNGA S. (2014). Perceptions of adult trauma patients on the acceptability of text messaging as an aid to reduce harmful drinking behaviours. BMC Research Notes, 2014 7:4 DOI: 10.1186/10.1186/1756-0500-7-4

 

Top

2012-2013

WILKINS C, SHERIDAN J, ADAMS P, RUSSELL B, RAM S, NEWCOMBE D. (2013) The new psychoactive substances regime in New Zealand: a different approach to regulation. J Psychopharmacol July 2013 vol. 27no. 7 584-589

WOULDES, T. A. and WOODWARD, L. J. (2013). Maternal methadone dose during Pregnancy and infant clinical outcome. Response to O’Grady et al. Neurotoxicology and Teratology.  09/2013; 39C:119-121. DOI: 10.1016/j.ntt.2013.05.004

CURLEY LE, KYDD RR, KIRK IJ, RUSSELL BR (2013) Differential responses to anticipation of reward after an acute dose of the designer drugs benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) alone and in combination using functional magnetic resonance imaging (fMRI). Psychopharmacology

GALLAND, B. C., MITCHELL, E. A., E. A., THOMPSON, J. M. D., WOULDES, T. A. (2013). Auditory evoked arousal responses of 3-month-old infants exposed to methamphetamine in utero: a nap study. Acta Paediatrica, 102, 424-430.

SHERIDAN, J., YANG DONG C., BUTLER, R., BARNES, J. The impact of New Zealand's 2008 prohibition of piperazine-based party pills on young people's substance use: Results of a longitudinal, web-based study. The International Journal of Drug Policy, 03/2013; 24(5). DOI: 10.1016/j.drugpo.2013.02.002

PARACKAL SM., PARACKAL M., HARRAWAY J. Prevalence and correlates of drinking in early pregnancy among women who stopped drinking on pregnancy recognition. Maternal and Child Health Journal, 2013 Apr 17(3):520-9. doi: 10.1007/s10995-012-1026-7 Available online

WOULDES, T. A., LAGASSE, L. L., DERAUF, C., NEWMAN, E., SHAH, R, SMITH, L. M., ARRIA, A. M., HUESTIS, M. A., DELLAGROTTA, S., WILCOX, T., NEAL Jr., C. R., LESTER, B. M. (2013). Co-morbidity of substance use disorder and psychopathology in women who use methamphetamine during pregnancy in the US and New Zealand. Drug and Alcohol Dependence, 127(1-3), 101-107.

WU, M., LAGASSE, L. L., WOULDES, T., WILCOX, T., DERAUF, C., NEWMAN, E., SHAH, R., SMITH, L. M., NEAL, C., HUESTIS, M. A., DELLAGROTTA, S., LESTER, B. M. (2013). Predictors of inadequate prenatal care in methamphetamine-using mothers in New Zealand and the United States. Maternal and Child Health Journal, 17:566-575.

SHERIDAN, J., ATMORE, B. and RUSSELL, B. (2012), New Zealand to establish fit for purpose regulation for new psychoactive substances. Addiction, 107: 1901–1902. doi: 10.1111/j.1360-0443.2012.03809.x

HUMENIUK, R., ALI, R., BABOR, T., SOUZA-FORMIGONI, M., BOERNGEN DE LACERDA, R., LING, W., MCREE, B., NEWCOMBE, D., PAL, H., POZNYAK, V., SIMON, S., VENDETTI, J. A Randomized Controlled Trial of a Brief Intervention for Illicit Drugs Linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in clients recruited from Primary Health Care Settings. Addiction. doi:10.1111/j.1360-0443.2011.03740.x , 107 95), 957-966. 2012

TEEVALE, T., ROBINSON, E., DUFFY, S., UTTER, J., NOSA, V., CLARK, T., SHERIDAN, J., AMERATUNGA, S. Binge drinking and alcohol-related behaviours amongst Pacific youth: a national survey of secondary school students. New Zealand Medical Journal, 125(1352). 60-70. 2012

SHERIDAN, J., STEWART, J., SMART, R., MCCORMICK, R. Risky drinking among community pharmacy customers in New Zealand and their attitudes towards pharmacist screening and brief interventions. Drug Alcohol Rev. 31(1):56-63, 2012

Top

2010-2011

WALKER N, WILLIMAN J, SHERIDAN J, NEWCOMBE D, MCROBBIE H, GALEA S. Nicotine receptor partial agonists for alcohol dependence [Protocol]. Cochrane Database of Systematic Reviews issue 12, 2011

NOSA, V, .ADAMS, P, .HODGES, I. Distinctive alcohol cultural practices amongst Niuean men living in Auckland, New Zealand, Kotuitui Journal, 6(1-2), 62-72, 2011

COHEN, B., BUTLER, R. A review of research on benzylpiperazine as a recreational drug. International Journal of Drug Policy, 22 (2), 95-101 2011

GALEA, S., LARUSSO, M., NEWCOMBE, D., WALTERS, C. Ibogaine – be informed before you promote or prescribe. Journal of Primary Health Care, Letter to the Editor. Journal of Primary Health Care, 3(1), 86-87.2011.

LIN, JC., JAN, RK., KYDD, RR., RUSSELL, BR. Subjective effects of party pill drugs BZP and TFMPP alone and in combination in humans. Drug testing and Analysis. In press

DEERING, DEA., SHERIDAN, J., SELLMAN, JD., ADAMSON, SJ., POOLEY, S., ROBERTSON, R., HENDERSON, C. Consumer and treatment provider perspectives on reducing barriers to opioid substitution treatment and improving treatment attractiveness. Addictive Behaviors 36(6):636-642 2011

HORSFIELD, E., SHERIDAN, J., ANDERSON, C. What do community pharmacists think about undertaking screening and brief interventions with problem drinkers? Results of a qualitative study in New Zealand and England. International Journal of Pharmacy Practice, 19(3), 192-200. 2011

ADAMSON, S., DEERING, D., SELLMAN, D., SHERIDAN, J.L., HENDERSON, C., ROBERTSON, R.S., POOLEY, S.A., CAMPBELL, S., FRAMPTON, C. An estimation of the prevalence of opioid dependence in New Zealand, International Journal of Drug Policy, 36, 636-642, 2011

SHERIDAN, J.L., BARNARD, M., WEBSTER, S. Influences on the provision of drug services in England: the experiences and views of front line treatment workers, Health and Social Care in the Community, 19(4), 403-411, 2011

LAGASSE, L.L., WOULDES, T.A., NEWMAN, E., SMITH, L.D.,SHAH, R.Z., DERAUF, C., HUESTIS, M.A., ARRIA, A.M., DELLA GROTTA, S., WILCOX, T., LESTER, B. M. Prenatal methamphetamine exposure and neonatal neurobehavioral outcome in the USA and New Zealand. Neurotoxicology and Teratology, 33, 166-175, 2011

PARACKAL, S.M., PARACKAL, M., HARRAWAY, J. Warning labels on alcohol containers as a source of information on alcohol consumption in pregnancy among New Zealand women. International Journal of Drug Policy. (21): 302-305, 2010

WOULDES, T.A. and WOODWARD, L. J. (2010). Maternal methadone dose during pregnancy and clinical outcome. Neurotoxicology and Teratology, 32(3), 406-417, 2010 WOULDES, T. A. What Healthcare Professionals Know and Do About Alcohol and Other Drug Use During Pregnancy. Report for the National Drug Policy of New Zealand, Ministry of Health and Alcohol Health Watch, 1-94. www.ahw.org.nz. 2010

LIN, J.C., JAN, R.K., LEE, H., JENSEN, M.A., KYDD, R.R., RUSSELL, B.R. Determining the subjective and physiological effects of BZP combined with TFMPP in human males. Psychopharmacology (Berl). Epub Nov 9. 2010

LEE, H.S., KYDD, R.R., LIM, V.K., KIRK, I.J., RUSSELL B,R. Effects of Trifluoromethylphenylpiperazine on interhemispheric communication. Psychopharmacology (Berl)Epub Oct 6 2010

ANTIA, U, TINGLE, M.D, RUSSELL, B.R. Validation of an LC-MS method for the detection and quantification of BZP and TFMPP and their hydroxylated metabolites in human plasma and its application to the pharmacokinetic study of TFMPP in humans, Journal of Forensic Science Epub Jun 8. Sep;55(5):1311-8. doi: 10.1111/j.1556-4029.2010.01457. 2010

SHERIDAN, J., BUTLER, R. Prescription drug misuse in New Zealand: challenges for primary healthcare professionals. Research in Social and Administrative Pharmacy. 2010 corrected proof

PULFORD, J., ADAMS, P., SHERIDAN, J. What do clients want from alcohol and other drug treatment services? A mixed methods examination. Addiction Research and Theory. Early online: DOI: 10.3109/16066359.2010.507893, 2010

SMART, R., MCCORMICK, I.R.N., SHERIDAN, J.L. Estimating problem drinking amongst community pharmacy customers: what did pharmacists think of the methodology?, International Journal of Pharmacy Practice, 18: 290–296, 2010

MCCORMICK, I. R., DOCHERTY, B., SEGURA, L., COLOM, J., GUAL, A., CASSIDY, P., KANER, E., HEATHER, N. The research translation problem: Alcohol screening and brief intervention in primary care - Real world evidence supports theory." Drugs: education, prevention and policy 17(6): 732-748. 2010

PULFORD J, ADAMS P and SHERIDAN J. Developing a clinical assessment model suited to use in an agency providing short-term substance use treatment: findings from a Delphi survey of expert opinion. Administration and Policy in Mental Health and Mental Health Services Research, 36(5): 322-330. 2010

KETTLER, L., NIKIC, M., NEWCOMBE, D., ALI, R. Mood disturbance and withdrawal severity in substitution treatment for opioid dependence: their association and impact on continued illicit drug use. Addictive Disorders and Their Treatment, 9(1). 1-7, 2010.

BUTLER, R.A., SHERIDAN, J.L., Innocent parties or devious drug users: the views of primary healthcare practitioners with respect to those who misuse prescription drugs, Harm Reduction Journal, 2010, 7:21 doi:10.1186/1477-7517-7-21http://www.harmreductionjournal.com/content/pdf/1477-7517-7-21.pdf

ADAMS, P.J; WARREN, H. Responding to the risks associated with the relapse of recovering staff members within addiction services, Substance Use and Misuse, 45, (6), 951-967. 2010

JAN, R.K., LIN, J.C., LEE, H., SHERIDAN, J.L., KYDD, R.R., KIRK, I.J., RUSSELL, B.R. Determining the subjective effects of TFMPP in human males, Psychopharmacology, 211 (3), 347-353, 2010

PULFORD, J., ADAMS, P.J., SHERIDAN, J.L. Responding to treatment dropout: a review of controlled trials and suggested future directions, Addiction Research and Theory, 18, (3), 298-315, 2010

WINSTOCK, A., LEA, T., SHERIDAN, J.L. Problems experienced by community pharmacists delivering opioid substitution treatment in New South Wales and Victoria, Australia, Addiction, 2010, 105(2):335-42

SHERIDAN, J.L., BUTLER, R.A. "They're legal so they're safe, right?" What did the legal status of BZP-party pills mean to young people in New Zealand?, International Journal of Drug Policy, 21(1), 77-81, 2010

MAYET, S., MANNING, V., SHERIDAN, J. BEST, D., STRANG, J. The virtual disappearance of injectable opioids for heroin addiction under the ‘British System’', Drugs: Education, Prevention, and Policy, 17(5): 496–506 2010

PULFORD, J., BLACK, S. WHEELER, A., SHERIDAN, J. ADAMS, P. Providing post treatment support in an out-patient alcohol, and other drug treatment context: a qualitative study of staff opinion, International Journal of Mental Health and Addiction, 8(3):493-502 2010 http://www.springerlink.com.ezproxy.auckland.ac.nz/content/0820x60p431p3023/fulltext.pdf

 

Top

2008-2009

LIN, J., BANGS, N., LEE, H.S., KYDD, R.R., RUSSELL, B.R. Determining the subjective and physiological effects of BZP on human females: Psychopharmacology Sept. 207:439–446 DOI 10.1007/s00213-009-1669-2). 2009

KOOL, B., AMERATUNGA, S., JACKSON, R. The role of alcohol in unintentional falls among young and middle-aged adults: a systematic review of epidemiological studies. Injury Prevention. 15(5):341-7, 2009

ANTIA, U., LEE, H.S., KYDD, R.R, TINGLE, M.D, RUSSELL, B.R. In vivo interactions between BZP and TFMPP - Party Pill drugs NZ Medical Journal, 122(1303);29-38. 2009

ANTIA, U., TINGLE, M.D, RUSSELL, B.R. 'Party pill' drugs - BZP and TFMPP. N Z Med J. Dec 11;122(1307):55-68. 2009

ANTIA, U., TINGLE M., RUSSELL BR, Metabolic interactions with Party Pill drugs. Journal of Pharmacy and Pharmacology 61 (7), pp. 877-882. 2009

MURPHY, M.E., ANTIA, U., CHANG, H., HAN, J., IBRAHIM, A., TINGLE, M., RUSSELL, B.R. Party Pills and Drug-Drug Interactions NZ Medical Journal April, 122(1293), 16-26. 2009

PARACKAL, S.M., PARACKAL, M., HARRAWAY, J., FERGUSON, E. Opinions of Non-pregnant New Zealand Women aged 16-40 years about the Safety of Alcohol Consumption during Pregnancy. Drug and Alcohol Review, 28(2): 135-141, 2009

ANTIA, U., LEE, H.S., KYDD, R.R., TINGLE, M.D., RUSSELL, B.R. Pharmacokinetics of‘party pill’ drug N-benzylpiperazine (BZP) in healthy human participants. Forensic Science International, 186, 63-67. 2009

PULFORD, J., ADAMS, P.J., SHERIDAN, J.L. Client/clinician discrepancies in perceived problem improvement and the potential influence on dropout response, International Journal of Mental Health and Addiction, 7,(4), 497-505, 2009http://www.springerlink.com/content/9110nwun8w5mq428/fulltext.pdf

BUTLER, R.A., WHEELER, A.J., SHERIDAN, J.L. Physical and Psychological Harms and Health Consequences of Methamphetamine Use Amongst a Group of New Zealand Users, International Journal of Mental Health and Addictions, 10.1007/s1, p-, 2009, 10.1007/s11469-009-9213-5

NOSA, V., OFANOA M. The Social, cultural and medicinal use of kava for twelve tongan born men living in Auckland, New Zealand in Pacific Health Dialogue, 15 (1), 96-102.2009

GRAY, J., NOSA, V. Tau Fifine Fiafia: The Binge Drinking Behaviours of nine New Zealand born woman living in Auckland. In Pacific Health Dialogue, 15 (1) 104-111. 2009

WINSTOCK, A., LEA, T., SHERIDAN, J.L. What is diversion of supervised buprenorphine and how common is it?, Journal of Addictive Diseases, 28,(3), 269-278, 2009 S

HERIDAN, J.L., BUTLER, R.A., WHEELER, A.J. Initiation into methamphetamine use: qualitative findings from an exploration of first time use amongst a group of New Zealand users, Journal of Psychoactive Drugs, 41(1), p11-17, 2009

PULFORD, J., ADAMS, P.J., SHERIDAN, J.L. An investigation into whether clients and/or their respective clinicians are aware of pending service exit in the first two months of treatment admission, Drug and Alcohol Review, Online, pDOI: 10.1111/j.1-DOI: 10.1111/j.1, 2009

WOULDES, T. A. Healthcare Professionals Knowledge and Practice of Alcohol and Drug Consumption in Pregnant Women and Women of Childbearing Age. Results of Qualitative Study and Report for Alcohol Healthwatch: Auckland, New Zealand, 1-48. 2008

LAWRINSON, P., ALI, ROBERT., BUAVIRAT, A., CHIAMWONGPAET, S., DVORYAK, S., HABRAT, B., JIE, S., MARDIATI, R., MOKRI, A., MOSKALEWICZ., NEWCOMBE, D., POZYNAK, V., SUBATA, E., UCHTENHAGEN, A., UTAMI, D.S., VIAL, R., ZHAO, C.. Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS. Addiction, 103, 1484-1492, 2008.

WINSTOCK, A., LEA, T., SHERIDAN, J.L. Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia, International Journal of Drug Policy, March, Available online-Available online, 2008

PULFORD, J., ADAMS, P.J., SHERIDAN, J.L. Therapist attitudes and beliefs relevant to client dropout revisited, Community Mental Health Journal, 44, 181-186, 2008

SHERIDAN, J.L., WHEELER, A.J., CHEN, L., HUANG, A. and 2 others Screening and brief interventions for alcohol: attitudes, knowledge and experience of community pharmacists in Auckland, New Zealand, Drug and Alcohol Review, 27, 380-387, 2008 MCCORMICK, I. R. N. Addiction Medicine. New Zealand Family Physician 35(2): 82-83. 2008

WINSTOCK, A., LEA, T., SHERIDAN, J.L. Patients' help-seeking behaviours for health problems associated with methadone and buprenorphine treatment, Drug and Alcohol Review, 27, 393-397, 2008

BERKS, J. MCCORMICK, INR. Screening for alcohol misuse in elderly primary care patients: a systematic literature review." International Psychogeriatrics .20(6):1090-103. 2008

SHERIDAN, J.L., MCMILLAN, K., WHEELER, A.J., LOVELL, C., LEE, A.W., AMERATUNGA, S.N. Methamphetamine and injury - a survey of individuals attending a one-day music festival in New Zealand: Piloting a new methodology, Journal of Substance Use, 13(1), 49-56, 2008

KOOL, B., AMERATUNGA, S., JACKSON, R., ROBINSON, E., CRENGLE, S. The contribution of alcohol to falls at home among working-aged adults. Alcohol. 42: 383 – 388, 2008

SHERIDAN, J.L., GOODYEAR-SMITH, F.A., BUTLER, R.A., WHEELER, A.J., GOHNS, A. Barriers to, and incentives for, the transfer of opioid-dependent people on methadone maintenance treatment from secondary to primary health care, Drug and Alcohol Review, 27(3), 178-184, 2008

Top

2006-2007

STRANG, J., MANNING, V., MAYET, S., RIDGE, G., BEST, D., SHERIDAN, J. Does opiate prescribing for addiction change after national guidelines? Methadone and buprenorphine prescribing to opiate addicts by general practitioners and hospital doctors in England, 1995-2005, Addiction, 102(5), 761-770. 2007

GOODYEAR-SMITH, F., MCCORMICK, I.R.N, PATON-SIMPSON G.R, STEWART A.W. Changes in AUDIT scores of Auckland general practitioner patients from 1995 to 2003, New Zealand Family Physician, 34,(4), 252-257. 2007

PARACKAL, S.M., FERGUSON, E.L., HARRAWAY, J.A. Alcohol and Tobacco consumption amongst 6-24 months post-partum New Zealand women. Maternal and Child Nutrition, 3, 40-51, 2007

PULFORD, J., MCCORMICK, R., WHEELER, A., FIRKIN, P., SCOTT, I., ROBINSON, G. Alcohol assessment: the practice, knowledge and attitudes of staff working in the general medical wards of a large metropolitan hospital. New Zealand Medical Journal 120(1257), U2608. 2007

SHERIDAN, J., BUTLER, R., WILKINS, C., RUSSELL, B. Legal piperazine-containing party pills – a new trend in substance misuse. Drug and Alcohol Review, 26(3), 335-343. 2007

MEYER, B., RAHMAN, R., SHEPHERD, RM. Hypomanic personality features and addictive tendencies. Personality and Individual Differences, 42, 801-810. 2007

LESTER, BM., ARRIA, AM., DERAUF, C., GRANT, P., LAGASSE, L., NEWMAN, E., SHAH, RZ., STEWART, S., WOULDES, T. Methamphetamine exposure: A rural early intervention challenge. Zero to Three, 26(4), 30-36. 2006

BUTLER, R., SHERIDAN, J., KAIRUZ, T. New Zealand community pharmacists, experiences in collecting information from purchasers of pseudoephedrine-containing products: findings from a qualitative study', Pharmaceutical Journal, 278, 491-494. 2007

BUTLER, R., SHERIDAN, J. Highs and lows: patterns of use, positive and negative effects of benzylpiperazine-containing party pills (BZP-party pills) amongst young people in New Zealand', Harm Reduction Journal, 4,(18), 1-10,2007

PULFORD, J., WHEELER, A. Documenting client attendance norms: raw data and implications for treatment practice. Journal of Substance Use 12(2), 95-102. 2007

GULBRANSEN, G. MCCORMICK, I. R. N. Drink to your health - is alcohol really cardioprotective? New Zealand Family Physician 34(2): 122-126. 2007

NEWCOMBE D., ALI, R on behalf of WHO Opioid Study Working Group. The WHO multi-site Collaborative Study on Substitution Therapy of Opioid Dependence and HIV/AIDS – Regional comparisons of findings related to HIV risk behaviours, health, and community benefits. Chinese Journal of Drug Dependence, 16(3), 203-211, 2007

MITCHELL, T.B., DYER, K.R., NEWCOMBE, D., SOMOGYI, A., WHITE, J. Fluctuations in (R, S)-methadone pharmacokinetics and response among long-term methadone maintenance patients, Addiction Biology, 11, 170-174, 2006.

CHRISTIE, G., MARSH, R., SHERIDAN, J., WHEELER, AJ., SUAALII-SAUNI, TM., BLACK, S., BUTLER, RA. The substances and choices scale (SACS) - the development and testing of a new alcohol and other drug screening and outcome measurement instrument for young people, Addiction, 102(9), 1390-1398. 2007

ROBINSON, G., WARREN, H., SAMU, K., WHEELER, A., MATANGI-KARSTON, H., AGNEW, F. Pacific healthcare workers and their treatment interventions for Pacific clients with alcohol and drug issues in New Zealand. New Zealand Medical Journal 119(1228): U1809.2006

MCCORMICK, I. R. N., BRYANT, L. J. M., SHERIDAN, J. L. GONZALEZ, J. New Zealand Community Pharmacist attitudes toward treating Opioid Dependent Clients. Drugs-Education Prevention and Policy 13(6): 363-375. 2006

KOOL, B. Investigating the association between alcohol and falls at home: a comparison of case-control and case-crossover methods. Australasian Epidemiologist, 13:3, 959-60, 2006

MCCORMICK, I. R. N., KALIN, C. HURIWAI, T. Alcohol and other drug treatment in New Zealand -one size doesn't fit all. New Zealand Medical Journal 119(1244). 2006

 

Top

2005

SHERIDAN, J., WHEELER, A., WALTERS, C. Health problems and help-seeking activities of methadone maintenance clients at Auckland Methadone Service (AMS): potential for community pharmacy service expansion? Harm Reduction Journal 2(1), 25. 2005

BUTLER, R., BAULD, L. The Parents' Experience: coping with drug use in the family, Drugs- Education Prevention and Policy, 12, (1), 35-46 2005

NEWCOMBE, D.A.L, HUMENIUK, R.E, and ALI, R. Validation of the World Health Organisation Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) and Pilot Brief Intervention: Phase II Study: Report of results from the Australian site, Drug and Alcohol Review, 24, 217-226, 2005

FUNK, M., WUTZKE, S. E., KANER, E. F., ANDERSON, P., PAS, L., MCCORMICK, I. R. N., GUAL, A., BARFOD, S. SAUNDERS, J. A multicountry controlled trial of strategies to promote dissemination and implementation of brief alcohol intervention in primary health care: findings of a World Health Organisation collaborative study. Journal of Studies on Alcohol 66: 379-388.2005

MCCORMICK, I. R. N. PATTON , B. Problem alcohol drinkers: detecting and intervening. New Zealand Family Physician 32(3): 191-194. 2005

Top